SCHEMBL7184448

SCHEMBL7184448

CCCOc1c(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)cc(CC)cc1CC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.44
DPP4 P27487 3/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1B1 Q16678 2/20 0.41
MAOB P27338 2/20 0.40
LMNA P02545 3/20 0.38
POLB P06746 1/20 0.38
PTPN1 P18031 1/20 0.37
CHRNA7 P36544 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
CAPN1 P07384 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181126 0.91 MAOB (0.46) ABCG2DPP4CYP1A1CYP1B1MAOB
SCHEMBL7180355 0.89 MAPT (0.42) ABCG2DPP4CYP1A1CYP1B1MAOB
SCHEMBL7177307 0.88 ABCG2 (0.45) ABCG2MAOBLMNAPTPN1KEAP1
SCHEMBL7181421 0.85 LMNA (0.38) ABCG2MAOBLMNAPOLBPTPN1
SCHEMBL7189298 0.84 DPP4 (0.47) ABCG2DPP4CYP1A1CYP1B1MAOB
SCHEMBL7180028 0.82 MAPT (0.43) DPP4CYP1A1CYP1B1MAOBLMNA
SCHEMBL7187235 0.81 DPP4 (0.42) ABCG2DPP4CYP1A1CYP1B1MAOB
SCHEMBL7192307 0.79 MAPT (0.47) ABCG2DPP4CYP1A1CYP1B1LMNA
SCHEMBL7190670 0.78 ALDH1A1 (0.43) ABCG2DPP4LMNAPTPN1KEAP1
SCHEMBL7179811 0.78 RXRA (0.43) ABCG2DPP4CYP1A1CYP1B1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed